Delivery Order SPE2DB24D1104-SPE2DB24FYAX3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,732,659 units of the prescription drug Vyvanse 40 mg capsules. The contract has a ceiling value of $5,456.81 and a completion date of September 9, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,254,686 units of the prescription medication Vyvanse (40 mg capsules) at a total ceiling value of $1,337.70. The contract is a firm fixed-price Delivery Order, with a period of performance through February 13, 2025. The award is part of a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,529,755 units of Vyvanse 20 mg capsules. The contract has a firm fixed price and a ceiling value of $1,473.92. It is not set aside for any specific business type. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for providing a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,768,080 units of Vyvanse 40 mg capsules, with a ceiling value of $1,337.70. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vyvanse 40 mg capsules, a prescription medication, with a ceiling value of $2,999.50 and a period of performance through November 12, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor. The $1,641.92 contract is for the supply of 4,565,712,501 units of the prescription drug Vyvanse 40 mg capsule. The order has a firm fixed price and an ultimate completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,060,938 units of the prescription medication Vyvanse 60 mg capsules. The contract has a firm fixed price of $1,143.32 and a period of performance through April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,471.24, is for the delivery of 4,566,626,257 units of the 20 mg capsule form of the prescription drug Vyvanse. The contract has a firm fixed price and is set to expire on December 5, 2024. This appears to be a specific delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,802.45, is for the delivery of 4,568,101,166 units of the prescription medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,391 units of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,931.73 and a completion date of August 9, 2024. The award is not associated with any set-aside program. This delivery order is part of a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FYAX3Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,282,842 units of the prescription drug Vyvanse (40 mg capsules) at a ceiling value of $2,289.34. The contract has a firm fixed price pricing type and does not utilize any set-aside designations. It is a child contract associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order contract has a period of performance through July 30, 2024 and was awarded on July 29, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/29/24 |